Fluorescence polarization assay for determining histidine decarboxylase activity

Details for Australian Patent Application No. 2005306477 (hide)

Owner Boehringer Ingelheim Pharmaceuticals, Inc.

Inventors Rajotte, Daniel; August, E. Michael

Agent Davies Collison Cave

Pub. Number AU-A-2005306477

PCT Pub. Number WO2006/055753

Priority 60/628,242 16.11.04 US

Filing date 15 November 2005

Wipo publication date 26 May 2006

International Classifications

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/533 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with fluorescent label

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/055753 Priority application(s): WO2006/055753

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005306484-Triazole compounds that modulate Hsp90 activity

2005306476-Inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 and methods of using the same